Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Dogs with same orthopaedic conditions experience pain differently
The dogs that had the lowest-average owner-reported pain scores were dogs with elbow dysplasia. 

The findings reinforce the importance of using validated pain assessment tools. 

New research by the Royal (Dick) School of Veterinary Studies has shown that dogs with identical orthopaedic conditions can experience different levels of pain and impact on quality of life.

The study involved 200 dogs referred to the School’s Hospital for Small Animals with one of five orthopaedic conditions, including hip and elbow dysplasia, arthritis, and cruciate ligament injuries. Prior to treatment, owners complete two validated questionnaires measuring chronic pain and a quality-of-life survey assessing its impact on their dog’s everyday activities. 

Researchers found that the type of condition did not reliably predict how much pain a dog experiences or how much its quality of life was affected. However, they did observe considerable variation between individual dogs, even among those with the same diagnosis.

The dogs that had the lowest-average owner-reported pain scores were dogs with elbow dysplasia, while those with the highest were dogs with cranial cruciate. The team notes that pain levels varies widely within every group, indicating that diagnosis alone does not predict how severely an individual dog is affected.

The findings highlight the importance of using validated pain assessment tools during routine veterinary consultations. These tools provide a structured way to measure the impact of chronic pain on a dog’s life, allowing physicians to tailor treatments to each patients specific needs.

Researchers hope the wider use of validated pain assessment tools will support more personalised care for dogs with orthopaedic disease and guide future treatment decisions. 

Professor Dylan Clements, Professor of Small Animal Orthopaedics, said: “Just because a dog has a particular orthopaedic condition doesn't define how much that condition affects them. 

“We found huge variation between individual dogs, which reinforces the importance of assessing pain directly rather than making assumptions based on diagnosis alone. These clinical pain assessment tools can help veterinarians better understand each patient's needs and tailor treatment accordingly.”

Image (C) Josh Steele/Shutterstock.com

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.